These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29367412)

  • 1. "Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice." Stephen Y. Chan and Lewis J. Rubin.
    Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29367412
    [No Abstract]   [Full Text] [Related]  

  • 2. "Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension." Catherine E. Simpson, Jenny Y. Chen, Rachel L. Damico,
    Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 35484798
    [No Abstract]   [Full Text] [Related]  

  • 3. "Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension." Irene M. Lang and Sean P. Gaine. Eur Respir Rev 2015; 24: 630-641.
    Eur Respir Rev; 2016 Mar; 25(139):99. PubMed ID: 26929428
    [No Abstract]   [Full Text] [Related]  

  • 4. "Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension." Irene M. Lang, Sean P. Gaine. Eur Respir Rev 2015; 24: 630-641.
    Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28049123
    [No Abstract]   [Full Text] [Related]  

  • 5. "Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension." Irene Lang, Bernhard C. Meyer, Takeshi Ogo, Hiromi Matsubara, Marcin Kurzyna, Hossein-Ardeschir Ghofrani, Eckhard Mayer and Philippe Brenot.
    Eur Respir Rev; 2017 Jun; 26(144):. PubMed ID: 28615306
    [No Abstract]   [Full Text] [Related]  

  • 6. "Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms." S. Malenfant, M. Lebret, É. Breton-Gagnon,
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38355152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional deposition of inhaled hygroscopic aerosols: in vivo SPECT compared with mathematical modeling.
    Finlay WH; Stapleton KW; Chan HK; Zuberbuhler P; Gonda I
    J Appl Physiol (1985); 1996 Jul; 81(1):374-83. PubMed ID: 8828688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?" Irene M. Lang and Hiromi Matsubara.
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31649150
    [No Abstract]   [Full Text] [Related]  

  • 9. "Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis." Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58-64.
    Eur Respir Rev; 2015 Sep; 24(137):545. PubMed ID: 26324819
    [No Abstract]   [Full Text] [Related]  

  • 10. "Cellular mechanisms underlying steroid-resistant asthma." Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro.
    Eur Respir Rev; 2019 Dec; 28(154):. PubMed ID: 31722895
    [No Abstract]   [Full Text] [Related]  

  • 11. "Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing." Denis E. O'Donnell, Amany F. Elbehairy, Azmy Faisal, Katherine A. Webb, J. Alberto Neder and Donald A. Mahler. Eur Respir Rev 2016; 25: 333-347.
    Eur Respir Rev; 2016 Dec; 25(142):513. PubMed ID: 27903672
    [No Abstract]   [Full Text] [Related]  

  • 12. "Immune mechanisms in fibrotic pulmonary sarcoidosis". P. Weeratunga, D.R. Moller and L-P. Ho.
    Eur Respir Rev; 2023 Sep; 32(169):. PubMed ID: 37611949
    [No Abstract]   [Full Text] [Related]  

  • 13. "Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis." Bridget F. Collins and Ganesh Raghu.
    Eur Respir Rev; 2019 Dec; 28(154):. PubMed ID: 31722893
    [No Abstract]   [Full Text] [Related]  

  • 14. "The therapy of idiopathic pulmonary fibrosis: what is next?" Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi,
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31554706
    [No Abstract]   [Full Text] [Related]  

  • 15. "Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis." Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown.
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29653947
    [No Abstract]   [Full Text] [Related]  

  • 16. "Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats." R. Dumitrascu, C. Kulcke, M. Königshoff,
    Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 34916252
    [No Abstract]   [Full Text] [Related]  

  • 17. "Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis." M. Kolb, B. Crestani and T.M. Maher.
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38537950
    [No Abstract]   [Full Text] [Related]  

  • 18. "The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment." Silvia Ulrich and Ekkehard Grunig.
    Eur Respir J; 2021 Mar; 57(3):. PubMed ID: 33767003
    [No Abstract]   [Full Text] [Related]  

  • 19. "Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension." Mark Toshner, Colin Church, Lars Harbaum,
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 35798371
    [No Abstract]   [Full Text] [Related]  

  • 20. "How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?". G. Hardavella, A. Frille, R. Chalela, K.B. Sreter, R.H. Petersen, N. Novoa and H.J. de Koning.
    Eur Respir Rev; 2024 Jul; 33(173):. PubMed ID: 39142712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.